Bone tissue engineering (BTE) has emerged as a promising strategy for addressing bone defects and disorders that cannot be repaired through traditional methods. This field leverages the potential of various biomaterials, cells, and bioactive factors to promote bone regeneration. Mesenchymal stem cells (MSCs) have gained significant attention due to their osteogenic potential, which can be enhanced through osteoinductive factors. Osteoinductive factors, including growth factors like BMPs, TGF-β, VEGF, and IGF, play a crucial role in stimulating the osteodifferentiation process, thereby promoting bone regeneration. Furthermore, bioprinting technologies have opened new avenues for precisely designing scaffolds that can mimic the native bone architecture and provide a conducive environment for MSC differentiation. The integration of bioprinting with mesenchymal stem cells and osteoinductive factors has the potential to revolutionize regenerative therapies by allowing for the creation of patient-specific bone grafts. This review highlights the latest developments in MSC-based therapies, the role of osteoinductive factors, and the impact of bioprinting in advancing BTE. It also discusses future directions for improving the efficacy and clinical translation of these technologies.
30 September 2020 in Current Stem Cell Research & Therapy
Mesenchymal stem/stromal cells (MSCs) are localized throughout the adult body as a small population in the stroma of the tissue concerned. In injury, tissue damage, or tumor formation, they are activated and leave their niche to migrate to the site of injury, where they release a plethora of growth factors, cytokines, and other bioactive molecules. With the accumulation of data about the interaction between MSCs and tumor cells, the dualistic role of MSCs remains unclear. However, a large number of studies have demonstrated the natural anti-tumor properties inherent in MSCs, so this is the basis for intensive research for new methods using MSCs as a tool to suppress cancer cell development. This review focuses specifically on advanced approaches in modifying MSCs to become a powerful, precision- targeted tool for killing cancer cells, but not normal healthy cells. Suppression of tumor growth by MSCs can be accomplished by inducing apoptosis or cell cycle arrest, suppressing tumor angiogenesis, or blocking mechanisms mediating metastasis. In addition, the chemosensitivity of cancer cells may be increased so that the dose of the chemotherapeutic agent used could be significantly reduced.
1 January 2020 in Biotechnology & Biotechnological Equipment
Mesenchymal stem cells (MSCs) migrate to sites of inflammation and tumor formation in the body. In this way, MSCs become activated and release a plethora of growth factors and cytokines that are involved in the regulation and remodeling of the tumor microenvironment. The effect of MSCs on tumor cells is bipolar by nature and the data on this interaction is quite contradictory. The purpose of this work is to investigate the interaction between MSCs of different origin (bone marrow, adipose tissue) and PC-3 tumor cell line derived from prostate cancer in a long-term (9 days) cultivation. Our study assessed the proliferation, vitality and apoptosis of PC-3 tumor cells exposed to MSCs’ contact and products. As a result, we observed a significant growth inhibitory effect on PC-3 cells due to cell-to-cell contact with MSCs. Furthermore, tumor cells also showed contact-mediated increase in apoptosis levels. In addition, bone marrow-derived MSCs had a stronger effect on the PC-3 cell line compared to adipose tissue-derived MSCs.
28 March 2025 in Proceedings of the Bulgarian Academy of Sciences
Granulosa cells represent an essential part of the ovary's somatic compartment that maintains oocyte development and maturation and also provides the hormonal environment necessary to coordinate uterine receptivity with ovulation and, subsequently, to sustain early pregnancy. Primarily due to their major role in the processes of steroidogenesis and folliculogenesis, the study of granulosa cells is likely to be essential for comprehending and elucidating the cellular and molecular mechanisms underlying ovarian development and functions in both physiological and pathological conditions. Density gradient centrifugation is the primary method for the isolation of these cells from follicular fluid. However, this technique is time-consuming and in demand of additional reagents, experience, and dexterity. Furthermore, the limited half-life and proliferative potential of human granulosa cells put additional challenges for their study, making the conventional approaches for cultivation less applicable. Our aim was to develop dependable and effective protocols for the isolation and long-term cultivation of primary granulosa cells while preserving their functional and morphological characteristics. Human granulosa cells were isolated from follicular fluid by centrifugation and treatment with hyaluronidase without using density gradient centrifugation and/or red blood cell lysis buffer procedures. Steroidogenesis, growth dynamics, and the population doubling time of granulosa cells cultivated in a newly designed expansion medium, were determined. The medium consisted of DMEM/F12 supplemented with 5% human serum and 33% human follicular fluid. The isolation technique described in this study ensures the generation of granulosa cells with a very high level of purity. Granulosa cells cultivated in the newly developed expansion medium actively grew without changing morphologically and without losing the ability to produce estradiol and progesterone. Moreover, in this particular expansion medium, granulosa cells demonstrated a significantly increased proliferation rate, with a much shorter population doubling time compared to the control cultures grown in medium containing fetal bovine serum. Here we present a simple, fast, and cost-effective procedure for human granulosa cell isolation, combined with a reliable approach for their rapid growth and long-term cultivation based on a newly formulated expansion medium. Together, these two methods provide a comprehensive system for generating granulosa cell cultures, enabling their extensive study for the purposes of reproductive biology and medicine.
1 January 2020 in Biotechnology & Biotechnological Equipment
Hip replacement is one of the most effective surgical procedures in medicine. Despite the fact that the clinical results of arthroplasty are usually excellent, some implants loosen with time and require revision. To help resolve this problem, research has focused on providing conditions that have a positive biological effect on bone building elements, resulting in a fast, seamless proliferation and differentiation of mesenchymal stem cells (MSC) into osteoblasts. That is why developing an in vitro model for studying MSC functions at the implant–tissue contact zone is essential. The aim of this study was to investigate the proliferation and differentiation capacity of human bone-marrow derived MSC in contact with medical implant-grade Ti-6Al-4V alloy and β-tricalcium phosphate (β-TCP). Human MSC were isolated from bone marrow aspirates obtained from the femoral canal during hip replacement surgeries and seeded on Ti-6Al-4V alloy squared specimens and β-TCP granules. The results indicate that MSC were able to effectively adhere to both biomaterial surfaces and, at the same time, retain their proliferative and osteogenic/adipogenic differentiation potential. We suggest that both Ti-6Al-4V alloy and β-TCP surfaces provide suitable conditions for the proliferation and differentiation of bone marrow MSC and can be used as in vitro models to explore MSC functions at the bone–implant interface.